Press Releases

WASHINGTON, DC -- (MARKET WIRE) -- 02/10/12 -- The US-China Business Council (USCBC) issued the following statement today:

"Working together, the United States and China have a tremendous opportunity to build stronger economies and improve the lives of people around the world," said Muhtar Kent, Chairman and CEO of The Coca-Cola Company and Chair of the US-China Business Council. "The statement issued by USCBC's board of directors identifies key actions that will further strengthen this critical bilateral relationship and bring economic growth and job creation to our two countries and the world."

"The USCBC board of directors supports a strong, mutually-beneficial commercial relationship with China. The relationship has grown significantly over the past three decades thanks to the collaborative work of the governments, business communities, and other stakeholders in both countries," said USCBC President John Frisbie. "However, more work needs to be done to develop commercial ties and tackle unresolved issues."

The purpose of the statement is to bring greater focus on the issues that will increase commercial opportunities for American companies.

"USCBC calls upon the US and Chinese governments to work together on the USCBC statement of priorities. USCBC believes these steps will improve the US-China commercial relationship and lends its full support to achieving these important goals. The world-class membership of USCBC's board is committed to seeking solutions that foster economic growth," concluded Frisbie.

USCBC Board of Directors Statement of Priorities is available here: https://www.uschina.org/public/documents/2012/02/board_priorities.pdf

Highlights from the USCBC Board of Directors Statement of Priorities:

Ensure fair and open investment environments that create jobs. The United States and Chinese governments should jointly affirm the principle that foreign direct investment is good for economic development, employment, innovation, competition, consumers, and public welfare.

Reduce investment ownership restrictions in China and encourage Chinese investment in the United States. China has far too many ownership restrictions on US and foreign investors seeking market access. More investment by Chinese companies in the US means more jobs for Americans.

Remove unnecessary visa barriers. Both the US and Chinese government should agree to offer reciprocal five-year, multiple-entry visas for business travelers.

Continue to use WTO cases to settle trade disputes. Both countries have effectively used this channel to resolve trade disputes in a non-politicized manner and should continue to do so.

Further improve rule-making transparency. China's central government has significantly improved rule-making transparency over the past several years, but further improvements are needed. China should fully implement its commitment to publish all draft trade and economic-related laws, administrative regulations and departmental rules for a full 30-day period.

Increase financing support for US exports to China. Despite substantial growth in US exports to China over the past decade, the US share of Chinese imports has fallen to 7 percent from 10 percent in 2000. A worthy goal of the Obama administration's National Export Initiative should be to reclaim a 10 percent share of China's imports by 2014. Reauthorize the Export-Import Bank of the United States and have it prioritize lending support of US exports to China.

Eliminate duplicative and inconsistent payroll taxes. The US and China should quickly move to ensure its respective companies and employees are not required to pay payroll taxes (social insurance taxes in China) in both countries.

Adopt a stronger deterrent against counterfeiting. China should adopt the WTO-consistent deterrent of criminal penalties in cases of commercial-scale infringement, and broaden the use of higher penalties and stronger deterrents against all types of IPR infringement, including patent, copyright, trademark, and trade secrets violations.

Adhere to non-discriminatory, mutually-beneficial innovation policies. China should continue to implement its pledge to delink its innovation and government procurement policies. This issue impacts the level playing field for American companies in the China market, but also impedes China's goal of becoming a more innovative economy.

The US-China Business Council (USCBC) is a private, nonpartisan, nonprofit organization of roughly 240 American companies that do business with China. For nearly four decades, USCBC has provided unmatched information, advisory, advocacy, and program services to its membership. Through its offices in Washington, DC; Beijing; and Shanghai, USCBC is uniquely positioned to serve its members' interests in the United States and China.

Contact in Washington, DC:
Marc Ross
(Email Contact)
O: 202-429-0340
C: 202-596-5270

Source: The US-China Business Council

TORONTO, ONTARIO -- (MARKET WIRE) -- 02/10/12 -- CardioComm Solutions, Inc. (TSX VENTURE: EKG) has entered into a five year renewable Software License and Services Agreement with Royal Philips Electronics in which CardioComm Solutions will integrate their proprietary GEMS" (Global ECG Management System) software into Philips' ECG management services.

"We have spent the past three years compiling solutions to enable the integration of multiple FDA, Health Canada and CE cleared/approved ECG recording and transmitting devices with GEMS". Through experience with working with clients such as Philips, CardioComm Solutions is able to provide innovations that support the business and medical care challenges associated with the growing ECG monitoring markets," said Etienne Grima, CardioComm Solution's CEO. "This agreement demonstrates our ongoing commitment to developing solutions to serve these markets."

The agreement also extends licensing for a remote cardiac monitoring CardioComm Solutions ECG SDK viewer license, under which CardioComm Solutions' ECG SDK software is being utilized.

Royal Philips Electronics of the Netherlands is a diversified health and well-being company, focused on improving people's lives through timely innovations.

About CardioComm Solutions, Inc.

CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
CardioComm Solutions, Inc.
Etienne Grima
Chief Executive Officer
1-877-977-9425
egrima@cardiocommsolutions.com
www.cardiocommsolutions.com

Source: CardioComm Solutions, Inc.

TORONTO, ONTARIO--(Marketwire - Feb. 10, 2012) - CardioComm Solutions, Inc. (TSX VENTURE: EKG) has entered into a five year renewable Software License and Services Agreement with Royal Philips Electronics in which CardioComm Solutions will integrate their proprietary GEMS(TM) (Global ECG Management System) software into Philips' ECG management services.

"We have spent the past three years compiling solutions to enable the integration of multiple FDA, Health Canada and CE cleared/approved ECG recording and transmitting devices with GEMS(TM). Through experience with working with clients such as Philips, CardioComm Solutions is able to provide innovations that support the business and medical care challenges associated with the growing ECG monitoring markets," said Etienne Grima, CardioComm Solution's CEO. "This agreement demonstrates our ongoing commitment to developing solutions to serve these markets."

The agreement also extends licensing for a remote cardiac monitoring CardioComm Solutions ECG SDK viewer license, under which CardioComm Solutions' ECG SDK software is being utilized.

Royal Philips Electronics of the Netherlands is a diversified health and well-being company, focused on improving people's lives through timely innovations.

About CardioComm Solutions, Inc.

CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FOR FURTHER INFORMATION PLEASE CONTACT:
        CardioComm Solutions, Inc.
        Etienne Grima
        Chief Executive Officer
        1-877-977-9425
        egrima@cardiocommsolutions.com
        www.cardiocommsolutions.com

Source: CardioComm Solutions, Inc.